Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: J Pain. 2017 Dec 14;19(4):410–417. doi: 10.1016/j.jpain.2017.11.013

Table 1.

Demographics and screening blood test values.

ID Age Race Pain Free T3 Free T4 TSH Vit-D hsCRP ESR RBC WBC
ANALGESICS
1 39 Caucasian 9 3.2 1.15 1.23 14.6 1.47 10 4.56 9.08
2 37 Caucasian 4 86 (total) 1.3 0.99 27.8 0.86 6 4.24 8.38
3 21 Caucasian 6 2.8 1.23 0.60 55.9 0.9 0 4.42 2.67 pregabalin
4 46 Caucasian 3 2.1 0.77 2.10 29.3 3.66 14 4.55 8.35
5 27 Asian 7 3.4 11.3 (total) 3.00 6.3 0.32 4 5.11 6.09
6 24 Caucasian 5 90 (total) 6.3 0.92 16.7 0.45 5 4.41 6.84
7 26 African A 8 3.0 1.03 0.73 15.3 <0.2 10 4.69 4.41
8 39 African A 9 88 (total) 0.86 1.59 15.2 34.2 36 4.22 8.22 gabapentin

T3 = triiodothyronine (nanograms per deciliter; free unless indicated as total), T4 = thyroxine (nanograms per deciliter; free unless indicated as total), TSH = thyroid stimulating hormone (international units per milliter), Vit-D = vitamin D (nanograms per milliliter), hsCRP = high sensitivity C-reactive protein (milligrams per liter), ESR = erythrocyte sedimentation rate (millimeters per hour). RBC = red blood cell count (million per microliter), WBC = white blood cell count (thousand per microliter). No participants had detectable levels of anti-nuclear antibody or rheumatoid factor (not shown).

Pain values were collected from a single-item measure, “How would you rate your average daily pain on a scale from 0 (no pain at all) to 10 (worse possible pain)?”